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2019 Novel Coronavirus
Strategies for Optimizing the Supply of N95
Respirators
This document offers guidance on how to optimize supplies of N95 filtering facepiece respirators (commonly called “N95
respirators”) in healthcare settings in the face of potential ongoing 2019 Novel Coronavirus (2019-nCoV) transmission in
the United States. The recommendations are intended for use by professionals who manage respiratory protection
programs, occupational health services, and infection prevention programs in healthcare institutions to protect
healthcare personnel (HCP) from job-related risks of exposure to infectious respiratory illnesses.
Controlling exposures to occupational hazards is a fundamental way to protect personnel. Traditionally, a hierarchy of
controls approach has been used to achieve feasible and effective control. Some of the control measures may fall into
multiple categories. It should also be emphasized that multiple control strategies can be implemented concurrently and
or sequentially. This hierarchy can be represented as follows:
Elimination
Substitution
Engineering controls
Administrative controls
Personal protective equipment (PPE)
To prevent infectious disease transmission, elimination (physically removing the hazard) and substitution (replacing the
hazard) are not typically options for the healthcare setting. However, exposures to transmissible respiratory pathogens in
healthcare facilities can often be reduced or possibly avoided through engineering and administrative controls and PPE.
Prompt detection and effective triage and isolation of potentially infectious patients are essential to prevent unnecessary
exposures among patients, HCP, and visitors at the facility.
N95 respirators are the PPE most often used to control exposures to infections transmitted via the airborne route,
though their effectiveness is highly dependent upon proper fit and use. It is important to recognize that the optimal way
to prevent airborne transmission is to use a combination of interventions from across the hierarchy of controls, not just
PPE alone. Applying a combination of controls can provide a degree of protection, even if one intervention fails or is not
available.
Respirators, when required to protect HCP from airborne contaminants such as infectious agents, must be used in the
context of a comprehensive, written respiratory protection program that meets the requirements of OSHA’s Respiratory
Protection standard . The program should include medical evaluations, fit testing, and training.
Supplies of N95 respirators can become depleted during pandemics or when otherwise in high demand. Existing CDC
guidelines recommend a combination of approaches to conserve supplies while safeguarding HCP in such circumstances.
These existing guidelines recommend that healthcare facilities:
Minimize the number of HCP who need to use respiratory protection through the preferential use of engineering
and administrative controls;
Use alternatives to N95 respirators (e.g., other classes of filtering facepiece respirators, elastomeric half-mask and
full facepiece air-purifying respirators, powered air-purifying respirators) where feasible;
Implement practices allowing extended use and/or limited reuse of N95 respirators, when acceptable; and
Prioritize the use of N95 respirators for those HCP at the highest risk of acquiring infection or experiencing
complications of infection.
Engineering controls reduce exposures for HCP by placing a barrier between the hazard and the HCP. Engineering
controls can be very effective as part of a suite of strategies to protect HCP without placing primary responsibility of
implementation on them (i.e., they function without HCP having to take an action). This set of controls should already be
implemented in healthcare settings. In the continuum of surge capacity and standards of care, these measures can be
categorized as conventional capacity, which consists of providing patient care without any change in daily practices.
Patients with known or suspected 2019-nCoV (i.e., person under investigation [PUI]) should be placed in an airborne
infection isolation room (AIIR) that has been constructed and maintained in accordance with current guidelines, as
recommended in the Interim infection prevention and control recommendations for patients with confirmed 2019 novel
coronavirus or persons under investigation for 2019 nCoV in Healthcare Settings.
Barriers such as glass/plastic windows can be an effective solution for reducing exposures among HCP to potentially
infectious patients. This approach can be effective in reception areas (e.g., intake desk at emergency department, triage
station, information booth, pharmacy drop-off/pick-up windows) where patients may first report upon arrival to a
healthcare facility. Other examples include the use of curtains between patients in shared areas and closed suctioning
systems for airway suctioning for intubated patients.
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Engineering Controls
Another cornerstone of engineering controls are ventilation systems that provide air movement in a clean (HCP
workstation or area) to contaminated (sick patient) flow direction (along with appropriate filtration, exchange rate) that
are installed and properly maintained.
The term administrative controls refers to employer-dictated work practices and policies that reduce or prevent
hazardous exposures. Their effectiveness depends on employer commitment and HCP acceptance and consistent use of
the strategies. Regular training, monitoring and reinforcement are necessary to ensure that policies and procedures are
followed consistently. Many of these strategies should already be incorporated into existing infection prevention and
control policies in healthcare settings. In the continuum of surge capacity and standards of care, the following
administrative control measures can be categorized as conventional capacity, which consists of providing patient care
without any change in daily practices.
Limit number of patients going to hospital or outpatient settings
Consider developing mechanisms to screen patients for acute respiratory illness prior to their non-urgent care or elective
visits or procedures, such as through the appointment reminder system. Postpone and reschedule those with signs and
symptoms presenting for these non-acute visits.
Exclude HCP not directly involved in patient care
Limit the number of HCP who enter the patient’s room to only those providing direct patient care. Implement staffing
policies to minimize the number of HCP who enter the room and consider excluding staff such as dietary and
housekeeping employees.
Limit face-to-face HCP encounters with patient
Measures can be explored to limit face-to-face contact encounters between HCP and patients with confirmed or
suspected 2019-nCoV. HCP may consider bundling care activities to minimize room entries, and bundling may occur
across HCP types (e.g., food trays are delivered by HCP performing other care). Alternative mechanisms for HCP and
patient interactions include telephones, video monitoring, and video-call applications on cell phones or tablets.
Exclude visitors to patients with known or suspected 2019-nCoV patients (i.e., PUI)
Restrict visitors from entering the room of known or suspected 2019-nCoV patients (i.e., PUI), as recommended in the
Interim infection prevention and control recommendations for patients with confirmed 2019 novel coronavirus or
persons under investigation for 2019 nCoV in Healthcare Settings. Alternative mechanisms for patient and visitor
interactions, such as video-call applications on cell phones or tablets should be explored. Facilities can consider
exceptions based on end-of-life situations or when a visitor is essential for the patient’s emotional well-being and care. If
visitors must enter the room of a known or suspected 2019-nCoV patient, facilities should provide instruction, before
visitors enter patients’ rooms on use of PPE according to current facility policy while in the patient’s room.
Source control
Administrative Controls
Identify and assess patients who may be ill with or who may have been exposed to a patient with known 2019-nCoV.
Patients with symptoms of suspected 2019-nCoV or other respiratory infection (e.g., fever, cough) presenting to care
should use facemasks  for source control until they can be placed in an airborne infection isolation room or a private
room. Instructions should include how to use facemasks. Patients with these symptoms should not use N95 respirators.
If these patients need to leave their room for services in other areas of the hospital (e.g., radiology), they should also wear
facemasks for source control.
Cohorting patients
Cohorting is the practice of grouping together patients who are infected with the same organism to confine their care to
one area and prevent contact with other patients. Cohorts are created based on clinical diagnosis, microbiologic
confirmation when available, epidemiology, and mode of transmission of the infectious agent. Cohorting has been used
extensively for managing outbreaks of multidrug resistant organisms including MRSA, VRE, MDR-ESBLs, Pseudomonas
aeruginosa; methicillin-susceptible Staphylococcus aureus, RSV, adenovirus keratoconjunctivitis, rotavirus, and SARS.
When single patient rooms are not available, patients with confirmed 2019-nCoV may be placed in the same room.
Cohorting patients could minimize respirator use when extended wear of RPDs is implemented.  For more information
on cohorting of patients, refer to 2007 Guideline for Isolation  Precautions: Preventing Transmission of Infectious Agents
in Healthcare Settings .
Cohorting HCP
Assigning designated teams of HCP to provide care for all patients with suspected or confirmed 2019-nCoV could
minimize respirator use when extended wear of RPDs is implemented. This strategy can also limit the number of HCP
exposed to 2019-nCoV and limit the number of HCP who need to be fit tested.
Telemedicine
Nurse advice lines and telemedicine can screen and manage patients who may be infected with 2019-nCoV without the
need for the HCP to use RPDs. Promoting the use of these technologies and referral networks can help triage persons to
the appropriate level of care, potentially reducing the influx of patients to healthcare facilities seeking evaluation.
Training on indications for use of N95 respirators
It is also important that HCP be trained on indications for use of N95 respirators. The OSHA Respiratory Protection
standard requires employers to provide respirator training prior to requiring an employee to use a respirator in the
workplace. For example, HCP should use N95 respirators when caring for patients under airborne precautions for
infectious diseases including 2019-nCoV, tuberculosis, measles, and varicella. HCP should generally not need to use N95
respirators when caring for patients under droplet precautions for infectious diseases except under certain
circumstances (e.g., aerosol-generating procedures for influenza).
Training on use of N95 respirators
Training employees on the proper use of respirators, including putting on and removing them, limitations on their use,
and maintenance is essential for effective use of respiratory protection. HCP should be thoroughly trained before they
are fit tested to ensure they are comfortable donning the respirator and know how to conduct a user seal check. HCPs
should be trained on the respirator they are expecting to use at work.
Just in time fit testing
"
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Facilities may also adopt a plan to use the “just-in-time” method for fit testing, which has been incorporated into
pandemic plans for many facilities. For large facilities, it may not be feasible to fit test all employees, especially if their job
does not typically place them  at risk for exposure to airborne infectious diseases such as tuberculosis. These hospitals
have the capacity to do larger scale training and fit testing of employees when necessary during a pandemic. If healthcare
facilities are expecting to receive 2019 n-CoV patients, they should begin training and start to plan for fit testing now. It is
essential to have HCP trained and fit tested prior to receiving patients.
Limiting respirators during training
In order to conserve the supply of N95 respirators, healthcare facilities should be clear on which of their HCP do and do
not need to be in a respiratory protection program and thus medically evaluated, trained, and fit tested. If training and fit
testing are conducted during two separate steps, it may be possible to allow limited re-use of N95 respirators used by
individual HCP during both steps. Employees should be fit tested after they are comfortable donning the respirator and
have passed a user seal check. Employees should be trained on the respirator they are expecting to use at work. The
respirator can be saved and used for fit testing and patient care.
Qualitative fit testing
Respirator fit test methods are classified as either qualitative or quantitative, and there are multiple protocols of each
classification that are NIOSH-recommended or meet the requirements of OSHA’s Respiratory Protection Standard
qualitative fit test is a pass/fail test to assess the adequacy of respirator fit that relies on the individual’s sensory detection
of a test agent. A quantitative fit test numerically measures the effectiveness of the respirator to seal with the wearer’s
face, without relying on the wearer’s voluntary or involuntary response to a test agent. Quantitative fit tests involve
adaptation of the respirator to the fit testing equipment, which can involve making holes in the respirator.
Many healthcare systems already use qualitative fit test methods for fit testing HCP. For those using quantitative fit test
methods, considerations can be made to use qualitative fit test methods to minimize the destruction of an N95 respirator
used in fit testing and allow for the re-use of the same N95 respirator by the HCP. Qualitative fit methods may also allow
for rapid fit testing of larger numbers of HCP. Any switch in methods should be assessed to ensure proficiency of the fit
testers in carrying out the test.
While engineering and administrative controls should be considered first when selecting controls, the use of PPE should
also be part of a suite of strategies used to protect personnel. Proper use of respiratory protection by HCP requires a
comprehensive program (including medical clearance, training, and fit testing) that complies with OSHA’s Respiratory
Protection Standard  and a high level of HCP involvement and commitment. The program should also include
provisions for the cleaning, disinfecting, inspection, repair, and storage of respirators used by workers on the job. Proper
storage conditions can maximize shelf life of respirators. The following strategies are additional strategies that can be
considered by healthcare settings in the face of a potential N95 respirator shortage.
Conventional Capacity Strategies
The following two strategies may already be incorporated into existing infection prevention and control policies in
healthcare settings. In the continuum of surge capacity and standards of care, the following two measures can be
categorized as conventional capacity, which consists of providing patient care without any change in daily practices.
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Personal Protective Equipment and Respiratory Protection
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Surgical N95 respirators
Surgical N95 respirators (also referred as a medical respirator) are recommended only for use by HCP who need
protection from both airborne and fluid hazards (e.g., splashes, sprays). These respirators are not used or needed
outside of healthcare settings. In times of shortage, only HCP who are working in a sterile field or who may be exposed to
high velocity splashes, sprays, or splatters of blood or body fluids should be provided these respirators. Other HCP can
use standard N95 respirators. If surgical N95 respirators are not available, and there is a risk that the worker may be
exposed to high velocity splashes, sprays, or splatters of blood or body fluids, then a faceshield should be worn over the
standard N95 respirator.
Use of alternatives to N95 respirators
Use alternatives to N95 respirators  where feasible. These include other classes of filtering facepiece respirators,
elastomeric half-mask and full facepiece air purifying respirators, powered air purifying respirators (PAPRs) where
feasible. All of these alternatives will provide equivalent or higher protection than N95 respirators.
NIOSH approves other filtering facepiece respirators that are at least as protective as the N95. These include N99, N100,
P95, P99, P100, R95, R99, and R100.
Elastomeric respirators are sometimes referred to as reusable respirators because the facepiece is cleaned and reused
but the filter cartridges are discarded and replaced when they become unsuitable for further use. Similar to N95
respirators, elastomeric respirators require annual fit testing. Elastomeric respirators should not used in surgical settings
due to concerns that air coming out of the exhalation valve may contaminate the sterile field.
PAPRs are reusable respirators that are typically loose-fitting hoods or helmets. These respirators are battery-powered
with blower that pulls air through attached filters or cartridges. The filter is typically a high-efficiency particulate air
(HEPA) filter. Loose-fitting PAPRs do not require fit-testing and can be used with facial hair. However, PAPRs should not be
used in surgical settings due to concerns that the blower exhaust and exhaled air may contaminate the sterile field.
Facilities using elastomeric respirators and PAPRs should have up to date cleaning/disinfection procedures, which are an
essential part of use for protection against infectious agents.
Contingency Capacity Strategies
In the continuum of surge capacity and standards of care, the following two measures can be categorized as contingency
capacity, which may change daily practices but may not have any significant impact on the care delivered to the patient or
the safety of the HCP. The following measures may be considered in the setting of a potential impending shortage of N95
respirators.
Use of respirators after their intended shelf life
In times of increased demand and decreased supply, consideration can be made to use N95 respirators past their
intended shelf life. However, the potential exists that the respirator will not perform to the requirements for which it was
certified. Over time, components such as the strap and material may degrade, which can affect the quality of the fit and
seal. Prior to use of N95 respirators, the HCP should inspect the respirator and perform a seal check. Additionally, expired
respirators may potentially no longer meet the certification requirements set by NIOSH.
Extended use and limited reuse
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In the setting of a potential N95 respirator shortage, consider implementing practices allowing extended use and/or
limited reuse of N95 respirators, when acceptable. The decision to implement policies that permit extended use or
limited reuse of N95 respirators should be made by the professionals who manage the institution’s respiratory protection
program, in in consultation with their occupational health and infection control departments with input from the
state/local public health departments. CDC has recommended guidance on implementation of extended use and limited
reuse of N95 respirators in healthcare settings.
The decision to implement these practices should be made on a case by case basis taking into account known
characteristics of the 2019-nCoV and local conditions (e.g., number of disposable N95 respirators available, current
respirator usage rate, success of other respirator conservation strategies, etc.) Both Extended use and limited reuse have
been recommended and widely used as an option for conserving respirators during previous respiratory pathogen
outbreaks and pandemics.
Extended use refers to the practice of wearing the same N95 respirator for repeated close contact encounters with
several different patients, without removing the respirator between patient encounters. Extended use may be
implemented when multiple patients are infected with the same respiratory pathogen and patients are placed together in
dedicated waiting rooms or hospital wards.
Reuse refers to the practice of using the same N95 respirator by one HCP for multiple encounters with different patients
but removing it (i.e. doffing) after each encounter. N95 and other disposable respirators should not be shared by multiple
workers. The respirator is stored in between encounters to be put on again (i.e. donned) prior to the next encounter with
a patient. For pathogens for which contact transmission (e.g., contact with fomites) is not a concern (e.g., tuberculosis),
non-emergency reuse has been practiced for decades. For example, for tuberculosis prevention, CDC recommends that a
respirator classified as disposable can generally be reused by the same worker as long as it remains functional and is
used in accordance with local infection control procedures. Therefore, to extend the supply of N95 respirators during an
anticipated dwindling supply, HCP could be encouraged to practice limited reuse of their N95 respirators when caring for
patients with tuberculosis disease.
Even when N95 respirator reuse is practiced or recommended, restrictions are in place which limit the number of times
the same respirator is reused. Thus, N95 respirator reuse is often referred to as “limited reuse.” To maintain the integrity
of the respirator, it is important for HCP to hang used respirators in a designated storage area or keep them in a clean,
breathable container such as a paper bag between uses.  It is prohibited to modify the N95 respirator by placing any
material within the respirator or over the respirator. Modification may negatively affect the performance of the respirator
and could void the NIOSH approval.
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